Role of Exosomes in Biological Communication Systems 2020
DOI: 10.1007/978-981-15-6599-1_2
|View full text |Cite
|
Sign up to set email alerts
|

Characterization and Fine Structure of Exosomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 324 publications
0
2
0
Order By: Relevance
“…Differences in EV size and/or surface compounds affect the capturing by the objective or acceptor cells. For instance, micropinocytosis is technically consistent with the capture of isolated exosomes and small EVs, but not large EVs or small EV aggregates [ 33 , 34 ]. Moreover, EVs can be internalized and targeted to the lysosome for degradation or recycled and re-released into the extracellular fluids.…”
Section: Extracellular Vesicles As Alternative Therapeuticsmentioning
confidence: 99%
See 1 more Smart Citation
“…Differences in EV size and/or surface compounds affect the capturing by the objective or acceptor cells. For instance, micropinocytosis is technically consistent with the capture of isolated exosomes and small EVs, but not large EVs or small EV aggregates [ 33 , 34 ]. Moreover, EVs can be internalized and targeted to the lysosome for degradation or recycled and re-released into the extracellular fluids.…”
Section: Extracellular Vesicles As Alternative Therapeuticsmentioning
confidence: 99%
“…MVs are released from the cell membrane via direct budding, while exosomes are formed from multivesicular endosomes or multivesicular bodies [32]. Sorting of bioactive molecules such as RNA, miRNA, lipids, and metabolites is carried out through different ways of charging and loading into the EVs, as reviewed in [33]. Differences in EV size and/or surface compounds affect the capturing by the objective or acceptor cells.…”
Section: Extracellular Vesicles As Alternative Therapeuticsmentioning
confidence: 99%